Patent Assignment
Reel/Frame 064679/0315
Assignment of Assignor's Interest
Recorded: 2023-08-23
Pages: 6
Assignee
NAVIDEA BIOPHARMACEUTICALS, INC.
4995 BRADENTON AVENUE, SUITE 240, DUBLIN, OHIO, 43017
Covered Properties
(2)
Mannosylated Amine Dextran Drug Delivery Vehicles with Degradable Disulfide/Carbonate Linkers Targeting Payloads to CD206 Expressing Cells
Mannosylated Amine Dextran Drug Delivery Vehicles with Degradable Disulfide/Carbonate Linkers Targeting Payloads to CD206 Expressing Cells
Application:
63/388,777 →
Related Assignments
(3)
Other recorded transfers of the patents in this record — the chain of ownership.
Security Interest
Sep 26, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 068711/0393 →
Corrective Assignment to Correct the Receiving Party Information Previously Recorded on Reel 68711 Frame 393. Assignor(S) Hereby Confirms the Security Agreement.
Sep 27, 2024
From: NAVIDEA BIOPHARMACEUTICALS, INC.
To: SCOTT, JOHN KIM, JR.
Reel/Frame 069165/0332 →
Us Bankruptcy Court Sale Order Dated Jan. 30, 2026 to Release Security Interest Recorded at 069165 / 0332
Feb 12, 2026
From: SCOTT, JOHN KIM, JR.
To: NAVIDEA BIOPHARMACEUTICALS, INC.
Reel/Frame 074831/0644 →